MedTrace Logo

Exercise in Patients With Glioblastoma

NCT03390569 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2022-04-14

No results posted yet for this study

Summary

Patients with newly-diagnosed GBM will be given personalized exercise regimes during concurrent chemo-radiation and up to 3 months later. Study aims are to investigate the feasibility and preliminary efficacy of the exercise program on progression free survival. Secondary outcomes of interest include cognition, fatigue, and quality of life.

Conditions

Interventions

BEHAVIORAL

Exercise

The patients meet with a registered physiotherapist and receive individualized exercise programs starting the second week of treatment, and continuing up to 3 months later.

Sponsors & Collaborators

  • Canadian Cancer Society (CCS)

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • McMaster University

    collaborator OTHER

  • University of British Columbia

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Kim Edelstein, PhD, C.Psych. · University of Toronto, University Health Network

  • Warren Mason, MD · University of Toronto, University Health Network

  • Kristin Campbell, PhD · University of British Columbia

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-29
Primary Completion
2021-08-31
Completion
2021-12-23

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390569 on ClinicalTrials.gov